SenesTech (NASDAQ: SNES) develops fertility-control solutions designed to help manage rodent populations. The company was scheduled to release its second-quarter 2026 financial results after the market closed on August 5, 2026. Analysts estimated EPS of -$0.37 and revenue of approximately $601,500.
The revenue estimate followed news of significant operating growth. According to SenesTech, its active online subscription customer base more than doubled in the second quarter compared with the first quarter. This increase could support the company’s recurring-revenue strategy and improve future revenue visibility.
The subscriber growth was accompanied by a 186% increase in e-commerce revenue during the same period. SenesTech also introduced assessment services to help business customers evaluate the scale of rodent infestations and develop more effective management plans.
The negative EPS estimate is consistent with SenesTech’s recent lack of profitability. Its negative P/E ratio of -0.91 indicates that the company reported negative earnings over the relevant trailing period. Because earnings are negative, the P/E ratio is not meaningful for conventional valuation analysis.
Other reported financial ratios present a more positive picture. SenesTech’s Debt-to-Equity ratio of 0.34 suggests moderate leverage, while its Current Ratio of 8.91 indicates that current assets significantly exceed current liabilities. However, these ratios should be reviewed alongside the company’s cash-burn rate, operating losses, and future financing needs.
